Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Migraine, Vaccination site discolouration, Vaccination site erythema, Vaccination site mass
Clinical narrative: migraine; Vaccination site pruritus; Vaccination site erythema; vaccination site discoloration; Vaccination site mass; Burning sensation; Vaccination site warmth; Vaccination site tenderness; Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation), VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass) and MIGRAINE (migraine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046a21a and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Unspecified allergies.) since 03-Jan-2018, Diabetes since 05-Jan-2017 and Hypertension since 05-Jan-2017. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, MULTIVITAMINS [VITAMINS NOS] from 01-Jan-2007 to an unknown date and MULTIVITAMIN ACTIVE WOMAN from 01-Jan-2013 to an unknown date for an unknown indication.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced BURNING SENSATION (Burning sensation), VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PAIN (Vaccination site tenderness) and the first episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema). On 16-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass), VACCINATION SITE PRURITUS (Vaccination site pruritus) and the second episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema). On an unknown date, the patient experienced MIGRAINE (migraine). The patient was treated with HYDROCORTISONE for Itch, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Migraine, at a dose of 1 dosage form once a day. On 12-Apr-2021, BURNING SENSATION (Burning sensation) and VACCINATION SITE WARMTH (Vaccination site warmth) had resolved, VACCINATION SITE PAIN (Vaccination site tenderness) was resolving. On 19-Apr-2021, VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass) and VACCINATION SITE PRURITUS (Vaccination site pruritus) had resolved, last episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema) was resolving. At the time of the report, MIGRAINE (migraine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Patient demographics added, concomitant medication added, event out come updated, historical condition of the patient updated, 2nd dose information updated.